4D Molecular Therapeutics Eulerpool News

4D Molecular Therapeutics Aktie News

4D Molecular Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten 4D Molecular Therapeutics News stellen wir hier zusammen.

• 20. März ·

  Benzinga
  HC Wainwright & Co. Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target
• 9. Februar ·

  Yahoo
  4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
• 2. Februar ·

  Yahoo
  Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT)
• 19. Januar ·

  SeekingAlpha
  4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
• 14. Januar ·

  SeekingAlpha
  4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
• 27. Dezember ·

  Yahoo
  Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely
• 19. Dezember ·

  SeekingAlpha
  4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop
• 17. Dezember ·

  SeekingAlpha
  4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript
• 17. Dezember ·

  SeekingAlpha
  4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow
• 21. November ·

  Yahoo
  NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

4D Molecular Therapeutics Aktie Pressemeldungen

4D Molecular Therapeutics publiziert auf der Unternehmenswebseite regelmäßig Meldungen, die für Investoren relevant sind.